Antidepressant Strategies for Treatment of Acute Depressive Episodes Among Veterans
- 1 May 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Psychiatric Practice
- Vol. 29 (3) , 202-212
Abstract
Objective: The 2016 VA/DoD Clinical Practice Guideline for Management of Major Depressive Disorder offers consensus-based recommendations when response to the initial antidepressant medication is suboptimal; however, little is known about “real-world” pharmacological strategies used by providers treating depression in the Veterans Affairs Health Care System (VAHCS). Methods: We extracted pharmacy and administrative records of patients diagnosed with a depressive disorder and treated at the Minneapolis VAHCS between January 1, 2010 and May 11, 2021. Patients with bipolar disorder, psychosis-spectrum, or dementia diagnoses were excluded. An algorithm was developed to identify antidepressant strategies: monotherapy (MONO); optimization (OPM); switching (SWT); combination (COM); and augmentation (AUG). Additional data extracted included demographics, service utilization, other psychiatric diagnoses, and clinical risk for hospitalization and mortality. Results: The sample consisted of 1298 patients, 11.3% of whom were female. The mean age of the sample was 51 years. Half of the patients received MONO, with 40% of those patients receiving inadequate doses. OPM was the most common next-step strategy. SWT and COM/AUG were used for 15.9% and 2.6% of patients, respectively. Overall, patients who received COM/AUG were younger. OPM, SWT, and COM/AUG occurred more frequently in psychiatric services settings and required a greater number of outpatient visits. The association between antidepressant strategies and risk of mortality became nonsignificant after accounting for age. Conclusions: Most of the veterans with acute depression were treated with a single antidepressant, while COM and AUG were rarely used. The age of the patient, and not necessarily greater medical risks, appeared to be a major factor in decisions about antidepressant strategies. Future studies should evaluate whether implementation of underutilized COM and AUG strategies early in the course of depression treatment are feasible.Keywords
This publication has 16 references indexed in Scilit:
- Meta-analysis on the efficacy and tolerability of the augmentation of antidepressants with atypical antipsychotics in patients with major depressive disorderBrazilian Journal of Medical and Biological Research, 2014
- Thirty-Day Prevalence ofDSM-IVMental Disorders Among Nondeployed Soldiers in the US ArmyJAMA Psychiatry, 2014
- Predicting Risk of Hospitalization or Death Among Patients Receiving Primary Care in the Veterans Health AdministrationMedical Care, 2013
- Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and Long-Term Outcomes of a Single-Blind Randomized StudyAmerican Journal of Psychiatry, 2011
- The impact of PTSD, depression, and substance use disorders on disease burden and health care utilization among OEF/OIF veterans.Psychological Trauma: Theory, Research, Practice, and Policy, 2010
- No evidence for switching the antidepressant: systematic review and meta‐analysis of RCTs of a common therapeutic strategyActa Psychiatrica Scandinavica, 2010
- Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized TrialsAmerican Journal of Psychiatry, 2009
- Treatment of SSRI-Resistant Depression: A Meta-Analysis Comparing Within- Versus Across-Class SwitchesBiological Psychiatry, 2008
- Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D ReportAmerican Journal of Psychiatry, 2006
- Dose escalation for insufficient response to standard-dose selective serotonin reuptake inhibitors in major depressive disorderThe British Journal of Psychiatry, 2006